• Home
  • Ascendia Pharmaceuticals

Ascendia Pharmaceuticals

About Ascendia Pharmaceuticals

Ascendia is a specialty CDMO that provides custom formulations and manufacturing. Our experts deliver sophisticated formulations to enhance bioavailability, solubility and stability, while reducing toxicity using GRAS (Generally Regarded As Safe) materials and four proprietary nanotechnologies – NanoSol®, EmulSol®, AmorSol® and LipidSol®. Following formulation selection and optimization, Ascendia can scale-up a development program quickly to cGMP manufacturing of clinical materials. Ascendia’s manufacturing capabilities include sterile, injectables and orally administered dosage f...

Read more Show less
Certifications
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • US
  • 2017
    On CPHI since
  • 2
    Certificates
  • 50 - 99
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Meet us at

CPHI Americas 2025

Pennsylvania Convention Center, Philadelphia
20 May 2025 - 22 May 2025
View Exhibitor Profile

Products from Ascendia Pharmaceuticals (20)

  • Amorsol

    Product Amorsol

    Ascendia pharmaceuticals offers amorsol. Features: it is a technology for the production of amorphous solid dispersions. Solid dispersions are used to increase the dissolution rate, a limiting factor for the absorption of many compounds in development today. Contact us for more information.
  • cGMP clinical batches of injectable dosage forms

    Product cGMP clinical batches of injectable dosage forms

    Ascendia pharmaceuticals offers cGMP clinical batches of injectable dosage forms. Features: a dedicated, self-contained cleanroom for conducting sterile manufacturing and fill processes is maintained. Contact us for more information.
  • cGMP clinical batches of tablet and capsule dosage forms

    Product cGMP clinical batches of tablet and capsule dosage forms

    Ascendia pharmaceuticals offers cGMP clinical batches of tablet and capsule dosage forms. Features: it require capability to granulate, blend, and roller compact to make tablet batches for immediate release and modified release applications. Contact us for more information.
  • Emulsol

    Product Emulsol

    Ascendia pharmaceuticals offers emulsol. Features: it is a technology for production of oil-in-water nano-emulsions. Nano-emulsions are meta-stable, and a high level of input energy is required to produce a nano-emulsion. Contact us for more information.
  • Lyophilization

    Product Lyophilization

    Ascendia pharmaceuticals offers lyophilization. Features: it is an equipment for producing pharmaceutical formulations. Contact us for more information.
  • Micro-fluidizer

    Product Micro-fluidizer

    Ascendia pharmaceuticals offers micro-fluidizer. Features: it is an equipment for producing pharmaceutical formulations. Contact us for more information.
  • Nano-particle bead-milling

    Product Nano-particle bead-milling

    Ascendia pharmaceuticals offers nano-particle bead-milling. Features: it is an equipment for producing pharmaceutical formulations. Contact us for more information.
  • Nanosol

    Product Nanosol

    Ascendia pharmaceuticals offers nanosol. Features: it is a technology for the production of nano-sized drug particles. Formulation of a drug substance in nano-particle form significantly increases the surface area available for dissolution. Contact us for more information.
  • Nanosol

    Product Nanosol

    NanoSol is a technology for the production of nano-sized drug particles. Formulation of a drug substance in nano-particle form significantly increases the surface area available for dissolution.  A ten-to-twenty-fold increase in surface area can result from reducing particle size from a micronized dru...
  • Nanosol

    Product Nanosol

    NanoSol is a technology for the production of nano-sized drug particles. Formulation of a drug substance in nano-particle form significantly increases the surface area available for dissolution.  A ten-to-twenty-fold increase in surface area can result from reducing particle size from a micronized dru...
  • Nanosol

    Product Nanosol

    NanoSol is a technology for the production of nano-sized drug particles. Formulation of a drug substance in nano-particle form significantly increases the surface area available for dissolution.  A ten-to-twenty-fold increase in surface area can result from reducing particle size from a micronized dru...
  • Nmr and xrpd

    Product Nmr and xrpd

    Ascendia pharmaceuticals offers nmr and xrpd. Features: it is an analytical instrument for testing pharmaceutical formulations. Contact us for more information.
show all 20 products

Ascendia Pharmaceuticals Resources (4)

  • Pandemic and transformative technologies fuel growth in pharma outsourcing sector: CPHI North America panel

    News Pandemic and transformative technologies fuel growth in pharma outsourcing sector: CPHI North America panel

    Transformative technologies and the opportunities afforded by the COVID-19 pandemic have spurred investment in the life sciences outsourcing sector, according to a panel of industry experts speaking at CPHI North America on Monday.
    27 Jul 2021
  • Drug Formulation Development Process Notes From A CDMO

    Whitepaper Drug Formulation Development Process Notes From A CDMO

    Pharma R&D productivity has remained stagnant in the new millennium, despite record industry growth. While new technology has improved productivity in nearly every other sector, efficiency in pharmaceutical R&D is declining (or as described by MedCity News — “broken”).What obstacles are in the way of improving productivity in the pharmaceutical industry? How can we meet these challenges? At Ascendia Pharma, we’re proud to have innovative strategies in place to help our clients get their drugs from R&D to market faster.
  • 4 Factors Affecting Solubility of Drugs

    News 4 Factors Affecting Solubility of Drugs

    Bringing a new drug—or a new formula—to market is an exciting time for pharmaceutical companies, but getting the formulation correct can be challenging. Low aqueous solubility is a top concern encountered with formulation development of new chemical entities (NCEs). Improper drug solubility can lead to suboptimal drug delivery and absorption, resulting in ineffective drug efficacy and side effects. That's why solubility of drugs must be evaluated in the early stages of drug discovery.
    21 Jul 2021
  • Formulation Forum: Nanosuspension Dosage Forms

    News Formulation Forum: Nanosuspension Dosage Forms

    Nano-formulation of poorly water-soluble drugs has brought two proven benefits to commercial drug products. One is it enhances drug dissolution and oral bioavailability. Second, nano-formulation increases drug loading and release duration for parenteral drug delivery. In the June issue of issue of Drug Development & Delivery, Ascendia Pharma CEO Jim Huang, Ph.D., discusses one method of preparing nanosuspensions in his Formulation Forum column.
    21 Jul 2021